<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Detlef Schuppan, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Walburga Dieterich, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Celiac disease, also known as gluten-sensitive enteropathy, is a common immune-mediated inflammatory disease of the small intestine caused by sensitivity to dietary gluten and related proteins in genetically predisposed individuals. The epidemiology, pathogenesis, and clinical manifestations of celiac disease will be reviewed here. Its management and the use of antibodies for diagnosis are presented separately. (See  <a class="medical medical_review" href="/z/d/html/4777.html" rel="external">"Management of celiac disease in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOGENESIS</span></p><p class="headingAnchor" id="H3"><span class="h2">Genetic factors</span><span class="headingEndMark"> — </span>Celiac disease is an immune disorder triggered by an environmental agent (the gluten component of wheat and related cereals) in genetically predisposed individuals [<a href="#rid1">1,2</a>]. The genetic basis of celiac disease is supported by the frequent intrafamilial occurrence and the remarkably close association with the human leukocyte antigen (HLA) DR3-DQ2 and/or DR4-DQ8 gene locus. More than 99 percent of individuals with celiac disease have HLA DR3-DQ2 and/or DR4-DQ8, compared with 30 to 40 percent of the general population of most countries. Homozygosity for HLA DQ2 has been associated with an increased risk for celiac disease and enteropathy-associated T-cell lymphoma  (<a class="graphic graphic_table graphicRef96365" href="/z/d/graphic/96365.html" rel="external">table 1</a>) [<a href="#rid3">3-5</a>]. It has been estimated that the HLA contribution to the development of celiac disease among siblings is 36 percent [<a href="#rid6">6</a>]. Thus, another gene or genes at an HLA-unlinked locus must also participate [<a href="#rid7">7-11</a>]. Moreover, novel genetic and especially epigenetic factors that increase the risk or severity of celiac disease have been identified [<a href="#rid12">12</a>]. Celiac disease is associated with a number of autoimmune disorders, including type 1 diabetes mellitus and autoimmune thyroid disease [<a href="#rid13">13,14</a>]. A particular association was found with chromosome 15q26, which contains a type 1 diabetes susceptibility locus [<a href="#rid8">8,9,13</a>], and with chromosome 5q and possibly 11q [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/5899.html" rel="external">"Epidemiology, pathogenesis, and clinical manifestations of celiac disease in children", section on 'Genetic factors'</a>.)</p><p>Several non-HLA locus genes conferring risk for celiac disease have also been identified and an increasing number of non-HLA risk alleles have been associated with an increased risk of celiac disease [<a href="#rid10">10,11,15</a>]. Non-HLA genes that may influence susceptibility to the disease have been identified, but their influence has not been confirmed. However, these polymorphisms, even when taken together, contribute only 3 to 4 percent to the genetic risk for celiac disease, as compared with 30 to 40 percent for HLA-DQ2 or -DQ8.</p><p class="headingAnchor" id="H2939541393"><span class="h2">Mucosal immune response</span><span class="headingEndMark"> — </span>In patients with celiac disease, immune responses to gliadin fractions promote an inflammatory reaction, characterized by infiltration of the lamina propria and the epithelium with chronic inflammatory cells and villous atrophy. This response is mediated by both the innate and adaptive immune systems. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adaptive immune response  </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Gliadin reactive T cells</strong> – The adaptive response is mediated by gliadin (gluten)-reactive T-cells in the lamina propria that recognize gliadin peptides bound to HLA-DQ2 or -DQ8 on antigen-presenting cells. </p><p></p><p class="bulletIndent2">Tissue transglutaminase, a ubiquitous intracellular enzyme, deamidates gluten peptides, increasing their immunogenicity. Tissue transglutaminase is released by inflammatory and endothelial cells and fibroblasts in response to mechanical irritation or inflammation. Once it has been secreted, it crosslinks glutamine-rich proteins such as the gluten proteins from wheat. However, it can also deamidate glutamine residues in gluten to glutamic acid. Deamidation produces a negative charge in gluten peptides that increases their binding to HLA-DQ2 and -DQ8, which potentiates their capacity to stimulate T-cells [<a href="#rid16">16-18</a>].</p><p></p><p class="bulletIndent2">A 33 amino acid peptide (A-gliadin, peptide 56-89) that is particularly resistant to gastrointestinal peptidases may be the primary initiator of the inflammatory response to gluten in patients with celiac disease [<a href="#rid19">19</a>]. This peptide can be completely degraded by enterocytes in controls but only partly in celiac patients [<a href="#rid20">20</a>]. Enterocytes from patients with celiac disease show only limited digestion of peptide 31-49 of A-gliadin, a peptide that is not recognized by HLA-DQ2/DQ8. The high stability against proteolysis or the incomplete degradation of these gliadin peptides favors them as important initiators of the inflammatory response and toxic effects [<a href="#rid20">20</a>]. The key role of tissue transglutaminase in celiac disease pathogenesis has been confirmed in a phase 2 clinical study of 160 volunteers with celiac disease in remission who were challenged with 3 g daily of gluten, where an oral inhibitor of this enzyme largely prevented intestinal damage [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent2">Gluten peptide receptor(s) on intestinal epithelial cells may mediate the transport of gluten peptides to the lamina propria where T-cell activation occurs. A study found that CD71 (the transferrin receptor) was increased in patients with celiac disease and was also expressed at the apical pole of enterocytes, in contrast to its usual location at the basolateral pole of enterocytes [<a href="#rid22">22</a>]. CD71 colocalized with secretory IgA and seemed to be responsible for the apical to basal retro-transport of secretory IgA. Gluten peptides that are bound to secretory IgA (ie, IgA anti-gliadin antibodies) may be protected from degradation by the enterocytes, leading to accumulation in the lamina propria where T-cell stimulation occurs [<a href="#rid22">22</a>]. Gluten may also induce an increase in intestinal permeability in patients with celiac disease by binding to chemokine receptor CXCR3 found on enterocytes [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/z/d/html/5899.html" rel="external">"Epidemiology, pathogenesis, and clinical manifestations of celiac disease in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autoantibodies and intraepithelial lymphocytes</strong> – The relative pathogenic importance of humoral versus the established role of cellular immunity in the pathogenesis of celiac disease is uncertain. In a cell culture system, autoantibodies to tissue transglutaminase blocked intestinal epithelial differentiation [<a href="#rid17">17,24</a>]. Tissue transglutaminase may support the bioactivation of transforming growth factor beta 1, which is required for epithelial differentiation, a process that is impaired in celiac disease. Some inhibitory effect of isolated autoantibodies on tissue transglutaminase activity was also demonstrated in vitro [<a href="#rid25">25</a>]. However, residual enzymatic activity appears to be sufficient for protein crosslinking and (gluten) deamidation reactions [<a href="#rid26">26</a>]. Therefore, the mucosal tissue transglutaminase activity in celiac disease, which cannot be completely blocked by the locally produced autoantibodies, may have a role in the pathogenesis of celiac disease [<a href="#rid16">16,27</a>].</p><p></p><p class="bulletIndent1">The number of intraepithelial lymphocytes, which mainly bear the otherwise infrequent gamma-delta T-cell receptor, is increased in patients with active, gluten-sensitive celiac disease compared with normal subjects, while patients with refractory celiac disease also have aberrant lymphocytes with restricted gene rearrangements. The intraepithelial T lymphocytes show increased expression of interferon gamma and IL-10 [<a href="#rid28">28</a>]. However, the pathogenetic role of these lymphocytes, compared with the lamina propria lymphocytes, is controversial [<a href="#rid29">29</a>], and several inflammatory conditions, such as enteric infections and drug and food allergies that are unrelated to celiac disease, can cause intraepithelial lymphocytosis [<a href="#rid30">30,31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Innate immune response</strong> – Innate responses promote adaptive (T-cell-mediated) immunity in most autoimmune diseases and also in celiac disease. Triggers can be microbial but also chemicals, small molecules, or even food derived. Innate responses are usually sensed by pattern recognition receptors that are prominently expressed on myeloid immune cells, such as monocytes, macrophages, or dendritic cells. They usually lead to immediate immune responses to foreign invaders but can also exacerbate T-cell responses. Interleukin-15 is a prominent innate cytokine that promotes celiac disease [<a href="#rid32">32</a>], serving as a target for nondietary therapies [<a href="#rid33">33</a>]. Moreover, innate immunity elicited by non-gluten wheat proteins (in addition to gluten-mediated activation of pathogenic T-cells) is involved in and perhaps even necessary to trigger the gliadin-specific (adaptive) T-cell response in genetically predisposed individuals [<a href="#rid34">34</a>]. </p><p></p><p class="bulletIndent1">In celiac disease, gluten peptides have been implicated as triggers of innate immune responses not only in intestinal epithelial cells but also in mononuclear cells [<a href="#rid34">34-40</a>]. However, this was not confirmed in a study that identified a family of non-gluten proteins, the wheat amylase-trypsin inhibitors (ATIs), as activators of innate immunity in macrophages, monocytes, and dendritic cells via toll-like receptor 4, the receptor for bacterial lipopolysaccharide [<a href="#rid41">41</a>]. Notably, the ATIs regulate storage proteins and carbohydrates of the grain kernel and serve as pest-resistance proteins of gluten-containing cereals [<a href="#rid42">42-45</a>]. ATIs are highly resistant to intestinal digestion and induce low-level intestinal inflammation as well as intestinal dysbiosis after oral ingestion. They are possibly the major cause of non-celiac "gluten sensitivity" (more correctly "non-celiac wheat" sensitivity), which is defined as dose-dependent intolerance to gluten-containing cereals, with intestinal and extraintestinal manifestations, after exclusion of celiac disease or classical wheat allergy [<a href="#rid46">46,47</a>]. (See  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults", section on 'Differential diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H10"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>Celiac disease is not limited to individuals ethnically derived from European populations and has increasingly been found in populations of Northern Africa, the Middle East, India, and Northern China [<a href="#rid48">48</a>]. The estimated global prevalence of celiac disease based on serologic studies is approximately 1 percent [<a href="#rid49">49,50</a>]. Epidemiologic studies using serologic tests with biopsy verification have reported prevalences of 1:70 to 1:300 in most countries [<a href="#rid51">51</a>]. Even higher worldwide prevalences were reported by a systemic review and meta-analysis, with a prevalence of 1.4 percent based on serologic results and 0.7 percent found by biopsy results [<a href="#rid52">52</a>]. Overall, the global distribution of the disease seems to parallel the distribution of human leukocyte antigen (HLA) genotypes that predispose to celiac disease, provided that the population is also exposed to gluten [<a href="#rid53">53</a>]. </p><p>Population-based studies have suggested that recognized cases of celiac disease may only represent the tip of the celiac iceberg. As an example, a study from Italy reported that asymptomatic cases outnumbered symptomatic cases by a ratio of 7:1 [<a href="#rid54">54</a>]. Screening programs based upon antibody testing have demonstrated a high prevalence of celiac disease [<a href="#rid48">48,54-60</a>]. In European and United States cohorts, prevalence estimates range from 1:96 to 1:252 [<a href="#rid48">48,54,56-62</a>]. A large serologic screening study in the United States suggested a prevalence of 1:133 among patients with no risk factors or symptoms [<a href="#rid59">59</a>]. Analysis of self-reported data from the National Health and Nutrition Examination Surveys suggest that prevalence of individuals with celiac disease in the United States has remained stable between 2009 and 2014 [<a href="#rid63">63</a>]. In contrast, a study with Italian school-age children showed a significantly increased prevalence ranging from 0.88 percent when assessed between 1993 and 1995 up to 1.58 percent when assessed between 2015 and 2016 [<a href="#rid64">64</a>].</p><p class="headingAnchor" id="H506797419"><span class="h2">High risk groups</span><span class="headingEndMark"> — </span>First- and second-degree relatives of patients with celiac disease are at increased risk [<a href="#rid59">59,65</a>]. In a meta-analysis, the pooled prevalence of celiac disease was 8.9 percent (1:11) for siblings, 7.9 percent (1:13) for offspring, and 3 percent (1:33) for parents of the celiac patient [<a href="#rid65">65</a>]. </p><p>Other individuals at increased risk for celiac disease include (among several other autoimmune diseases):</p><p class="bulletIndent1"><span class="glyph">●</span>Type 1 diabetes</p><p class="bulletIndent1"><span class="glyph">●</span>Autoimmune thyroiditis</p><p class="bulletIndent1"><span class="glyph">●</span>Down and Turner syndromes</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary hemosiderosis (moderate risk)</p><p></p><p class="headingAnchor" id="H11"><span class="h1">TERMINOLOGY</span></p><p class="headingAnchor" id="H3547004262"><span class="h2">Symptomatic disease</span></p><p class="headingAnchor" id="H859325149"><span class="h3">Classic celiac disease</span><span class="headingEndMark"> — </span>The classic celiac disease or gluten-sensitive enteropathy is characterized by diarrhea or signs and symptoms of malabsorption (eg, steatorrhea, weight loss, or other signs of nutrient or vitamin deficiency) or both; villous atrophy; and resolution of the mucosal lesions and symptoms upon withdrawal of gluten-containing foods, usually within a few weeks to months [<a href="#rid66">66</a>]. Patients with classic disease possess antibodies against tissue transglutaminase. (See  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults", section on 'Serologic evaluation'</a>.)</p><p class="headingAnchor" id="H3170124767"><span class="h3">Atypical celiac disease</span><span class="headingEndMark"> — </span>Patients with atypical celiac disease lack classic symptoms of malabsorption but may exhibit minor gastrointestinal complaints. They usually have extraintestinal manifestations of celiac disease including anemia, dental enamel defects, osteoporosis, arthritis, increased aminotransferases, neurological symptoms, infertility, and several associated autoimmune diseases. These patients usually have villous atrophy in duodenal biopsies and display positive celiac antibodies, prominently against tissue transglutaminase. (See  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults", section on 'Serologic evaluation'</a>.)</p><p class="headingAnchor" id="H16"><span class="h2">Subclinical or asymptomatic disease</span><span class="headingEndMark"> — </span>Patients are asymptomatic and are identified incidentally during endoscopy performed for other indications  (<a class="graphic graphic_picture graphicRef65969" href="/z/d/graphic/65969.html" rel="external">picture 1</a>) or by serologic screening of high-risk groups for antibodies against tissue transglutaminase. The term "silent" may be a misnomer; after treatment with a gluten-free diet, many of these patients retrospectively recognize subclinical symptoms that they had not previously considered to be abnormal. Although these patients usually display the characteristic architectural remodeling of the intestinal mucosa, mainly villous atrophy, seen in classic celiac disease, they do not show classic clinical symptoms. </p><p>Establishing the diagnosis of subclinical or asymptomatic celiac disease is of potential importance due to the risk of malignancy, the presence of unsuspected nutritional deficiencies, and the association with low-birth weight infants in affected mothers. (See  <a class="medical medical_review" href="/z/d/html/4777.html" rel="external">"Management of celiac disease in adults"</a>.)</p><p class="headingAnchor" id="H4242336511"><span class="h2">Potential celiac disease</span><span class="headingEndMark"> — </span>The term is used for patients with positive celiac-specific serum antibodies but normal duodenal mucosal biopsy. Potential celiac disease is also used for patients with positive serology and increased intraepithelial lymphocytes (Marsh 1 lesion)  (<a class="graphic graphic_figure graphicRef60343" href="/z/d/graphic/60343.html" rel="external">figure 1</a>). These patients have no symptoms or laboratory signs of malabsorption. However, patients are at risk of developing classic celiac disease, and must be made aware of this possibility and should be monitored. </p><p class="headingAnchor" id="H4100810104"><span class="h2">Latent celiac disease</span><span class="headingEndMark"> — </span>Latent celiac disease was a previously used term for patients that presented with celiac disease in the past, usually diagnosed in childhood, but who recovered completely with a gluten-free diet and remained "silent" even once a normal diet was resumed [<a href="#rid67">67</a>]. Approximately 20 percent of such patients continued to be in remission (asymptomatic with normal villous architecture) into adulthood and were therefore classified as latent, while the others redeveloped variable degrees of villous atrophy [<a href="#rid68">68</a>]. Latency may be transient and thus regular follow-up of such patients is warranted. Moreover, diagnostic errors such as incorrect orientation and reading of duodenal biopsies may have obscured an otherwise positive histologic finding [<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H3292771917"><span class="h2">Refractory disease</span><span class="headingEndMark"> — </span>Refractory disease is defined by the persistence of symptoms and villous atrophy despite adherence to a gluten-free diet. Failure to improve on a gluten-free diet is mostly due to poor dietary compliance or other underlying malabsorptive disorders. However, in rare cases, diet-refractory celiac disease may be related to one of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Non-malignant inflammation of the small intestine, possibly due to a high sensitivity towards minimal amounts of gluten (refractory celiac disease type 1 [RCD1]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Semi-malignant inflammatory condition (RCD2).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Overt enteropathy-associated T-cell lymphoma (EATL).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Collagenous sprue, a very rare, little understood disorder, which is characterized by subepithelial collagen deposition [<a href="#rid70">70</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alternative diagnosis including autoimmune enteropathy, common variable immunodeficiency (CVID; IgG deficiency) or drug-induced villous atrophy.</p><p></p><p>Patients with refractory celiac disease type 2 or EATL have aberrant intraepithelial lymphocytes with restricted gene rearrangements; the relation of this finding to the resistance to gluten restriction is not known [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H4108365353"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Although classically a disease of infants, celiac disease now often presents later, between the ages of 10 and 40 years. Thus, the impressive clinical picture of a child with life-threatening malabsorption is often replaced by the mostly atypical presentation of adult celiac disease. This is in part due to longer periods of breast-feeding and the later introduction of gluten in the infant diet.</p><p>Thus, celiac disease represents a continuum with variable degrees of severity. The severity of symptoms appears to correlate with both histologic severity and tissue transglutaminase titers [<a href="#rid71">71,72</a>].</p><p class="headingAnchor" id="H607477084"><span class="h2">Gastrointestinal manifestations</span><span class="headingEndMark"> — </span>Patients may present with classic signs, including diarrhea with bulky, foul-smelling, floating stools due to steatorrhea and flatulence. These symptoms are paralleled by the consequences of malabsorption, such as weight loss, severe anemia, neurologic disorders from deficiencies of B vitamins, and osteopenia from deficiency of vitamin D and calcium. </p><p>Adult patients with undiagnosed celiac disease rarely present with profuse diarrhea and severe metabolic disturbances (celiac crisis) [<a href="#rid73">73</a>].</p><p>The severity of histologic changes in the small bowel does not necessarily correlate with the severity of clinical manifestations [<a href="#rid74">74</a>]. Although there is a gradient of decreasing severity from the proximal to the distal small intestine, correlating with the higher proximal concentration of dietary gluten, sampling error can occur due to spotty features of mucosal inflammation, or individual differences in gluten digestion and, therefore, a more proximal or distal maximal mucosal exposure to immunogenic gluten peptides. The histologic severity ranges from a mild alteration characterized by increased intraepithelial lymphocytes (type 1 lesion) to a flat mucosa with total mucosal atrophy, complete loss of villi, enhanced epithelial apoptosis, and crypt hyperplasia (type 3 lesion)  (<a class="graphic graphic_picture graphicRef76680" href="/z/d/graphic/76680.html" rel="external">picture 2</a> and <a class="graphic graphic_figure graphicRef60343" href="/z/d/graphic/60343.html" rel="external">figure 1</a>) [<a href="#rid66">66,67,75-78</a>]. (See  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults", section on 'Endoscopy with small bowel biopsy'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Extraintestinal manifestations</span><span class="headingEndMark"> — </span>A number of nongastrointestinal manifestations of celiac disease have been described. (See  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults"</a>.)</p><p class="headingAnchor" id="H1440723157"><span class="h3">Mucocutaneous</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermatitis herpetiformis</strong> – Dermatitis herpetiformis is common among patients with celiac disease. The classic clinical finding in dermatitis herpetiformis is the development of multiple intensely pruritic papules and vesicles that occur in grouped ("herpetiform") arrangements. The elbows, dorsal forearms, knees, scalp, back, and buttocks are among the most common sites for lesion development  (<a class="graphic graphic_picture graphicRef86749 graphicRef86750 graphicRef86751 graphicRef86752 graphicRef86768 graphicRef78315" href="/z/d/graphic/86749.html" rel="external">picture 3A-F</a>). The clinical manifestations, diagnosis, and management of dermatitis herpetiformis are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/15307.html" rel="external">"Dermatitis herpetiformis", section on 'Treatment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrophic glossitis</strong> – Oral lesions (erythema or atrophy) and a soreness or burning sensation of the tongue have been described in association with celiac disease and respond to a gluten-free diet [<a href="#rid79">79</a>]. Oral symptoms are frequent in patients with classical celiac disease, thus the involvement of the oral cavity is a helpful tool in diagnosis of celiac disease [<a href="#rid80">80</a>].</p><p></p><p class="headingAnchor" id="H340129880"><span class="h3">Metabolic bone disorders</span><span class="headingEndMark"> — </span>Metabolic bone disease is common in celiac disease and can occur in patients without gastrointestinal symptoms [<a href="#rid81">81-84</a>]. Patients with celiac disease may have bone loss due to secondary hyperparathyroidism from vitamin D deficiency [<a href="#rid85">85</a>]. Osteomalacia due to vitamin D deficiency is also sometimes seen, although its prevalence is unknown [<a href="#rid86">86</a>]. In adults, loss of bone density in the peripheral skeleton may persist despite apparent normalization at axial skeletal sites after patients are on a gluten-free diet [<a href="#rid85">85,87</a>]. </p><p>The risk of fractures is slightly increased in patients with celiac disease [<a href="#rid88">88</a>]. In a population-based cohort study in which 4732 patients with celiac disease were compared with 23,620 age- and sex-matched controls, the overall hazard ratio for any fracture was 1.3 (95% CI 1.16-1.46). The absolute difference in the overall fracture rate was 3.2 per 1000 person-years. </p><p>A higher prevalence of osteoarthritis has also been described in celiac disease, but whether there is a causal relationship is unclear [<a href="#rid89">89</a>]. </p><p class="headingAnchor" id="H691494908"><span class="h3">Hematologic</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Iron deficiency anemia </strong>– Celiac disease may be a surprisingly frequent cause of iron deficiency anemia [<a href="#rid90">90-92</a>]. One study of 93 patients presenting for evaluation of iron deficiency anemia found 11 (12 percent) with small bowel biopsy findings compatible with celiac disease [<a href="#rid93">93</a>]. Some had other mucosal abnormalities, such as esophagitis and gastritis, which could have been taken as the cause of the anemia and delayed the discovery of celiac disease. Similar findings were noted in another report in which 6 percent of 85 patients with iron deficiency anemia had celiac disease [<a href="#rid90">90</a>]. The incidence was 20 percent in the subgroup of nonresponders to supplemental iron.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyposplenism</strong> – Several case reports have described hyposplenism in association with celiac disease [<a href="#rid94">94-97</a>], the pathogenesis of which is unknown. (See  <a class="medical medical_review" href="/z/d/html/4777.html" rel="external">"Management of celiac disease in adults", section on 'Pneumococcal vaccination'</a>.) </p><p></p><p class="headingAnchor" id="H3510690373"><span class="h3">Neuropsychiatric</span><span class="headingEndMark"> — </span>Several reports have described an association between celiac disease and neurologic or psychiatric symptoms including headache, peripheral neuropathy, ataxia, epilepsy, depression, dysthymia, and anxiety [<a href="#rid98">98-113</a>]. However, these studies are limited by a small sample size, retrospective acquisition of data, tertiary referral bias, and potential misclassification of celiac disease, as the diagnosis in some studies was based on the presence of gliadin antibodies rather than duodenal histology or more specific autoantibodies. The association of celiac disease with depression and epilepsy is still unclear as studies have been conflicting [<a href="#rid114">114,115</a>]. </p><p>Peripheral neuropathies, characterized by burning, tingling, and numbness in hands and feet, have been described in up to 50 percent of patients with celiac disease and may precede its diagnosis [<a href="#rid99">99</a>]. In a large population-based study from Sweden that included 14,000 celiac patients and 70,000 controls, celiac disease was associated with an increased risk of polyneuropathy (hazard ratio 3.4), but not with other neurologic outcomes [<a href="#rid116">116</a>]. </p><p>In patients with celiac disease, neuropathies may also be associated with lymphoma and deficiencies of vitamins B1 (thiamine), B2 (riboflavin), B3 (niacin), B6 (pyridoxine), B12 (cobalamine), and E. However, vitamin deficiency syndromes are uncommon in the absence of severe and extensive small bowel involvement. </p><p>While a gluten-free diet has been shown to have a favorable effect on headache and dysthymia, it has not been demonstrated to improve peripheral neuropathies [<a href="#rid98">98,117</a>]. (See  <a class="medical medical_review" href="/z/d/html/5367.html" rel="external">"Overview of water-soluble vitamins"</a> and  <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">"Clinical manifestations and diagnosis of vitamin B12 and folate deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">"Overview of vitamin E"</a>.)</p><p class="headingAnchor" id="H26"><span class="h1">ASSOCIATED CONDITIONS</span></p><p class="headingAnchor" id="H1428224137"><span class="h2">Selective IgA deficiency</span><span class="headingEndMark"> — </span>Selective IgA deficiency has been associated with celiac disease and has been detected in up to 8 percent of patients with celiac disease in some studies [<a href="#rid118">118,119</a>]. Screening for celiac disease in patients with IgA deficiency is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults"</a>.)</p><p class="headingAnchor" id="H1359628356"><span class="h2">Autoimmune disease</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diabetes mellitus</strong> – Celiac disease is closely associated with type 1 diabetes mellitus and polyglandular autoimmune syndrome type III characterized by autoimmune thyroiditis combined with immune-mediated diabetes [<a href="#rid120">120-123</a>]. In several reports, between 2.6 and 7.8 percent of adults with type 1 diabetes had IgA autoantibodies to endomysium or to tissue transglutaminase; most such patients were proven to have celiac disease with small bowel biopsy [<a href="#rid124">124,125</a>]. Many such patients had no overt clinical manifestations of celiac disease [<a href="#rid124">124</a>]. Other reports have demonstrated that as many as 3.5 percent of children of parents with type 1 diabetes have celiac disease, the prevalence of which increases with age [<a href="#rid126">126</a>].</p><p></p><p class="bulletIndent1">Type 1 diabetes and celiac disease share multiple genetic loci such as HLA-DR3, HLA-DQ2 (HLA-DQ8), and several genetic variations [<a href="#rid8">8,127,128</a>]. This suggests that type 1 diabetes and celiac disease have common features in their pathogenesis, such as tissue damage from autoimmunity or intolerance to dietary antigens. Approximately one-third of patients with type 1 diabetes who have the celiac disease-predisposing haplotype HLA-DQ2 (which is found in 20 to 25 percent of the general Western population) have raised IgA autoantibodies to tissue transglutaminase and are therefore likely to have celiac disease [<a href="#rid129">129</a>]. This is in comparison to a prevalence of tissue transglutaminase autoantibodies in only 2 percent of those without HLA-DQ2.</p><p></p><p class="bulletIndent1">The age of onset and the severity of diabetes do not appear to be influenced by the presence of celiac disease [<a href="#rid124">124</a>]. Furthermore, celiac disease does not appear to trigger autoimmunity leading to diabetes as suggested in one report [<a href="#rid130">130</a>], since celiac autoantibodies usually develop after the onset of diabetes [<a href="#rid131">131</a>].</p><p></p><p class="bulletIndent1">Whether a gluten-free diet improves diabetes in patients with both diabetes and celiac disease is unclear. Only two small studies, one retrospective [<a href="#rid132">132</a>] and one short-term [<a href="#rid121">121</a>], investigated the effect of a strict gluten-free diet in patients with type 1 diabetes and silent celiac disease. Patients showed at best a trend toward an increased body mass index, but no change in folate or hemoglobin levels or insulin requirements. However, animal studies suggest that the interplay between gluten exposure and the intestinal immune system can modulate the development of type 1 diabetes. Substitutions of hydrolyzed casein instead of gluten in the diet delayed the onset of type 1 diabetes in BB rats, which spontaneously develop diabetes [<a href="#rid133">133</a>], and a gluten-free diet reduced the incidence of type 1 diabetes in non-obese diabetic mice from 64 to 15 percent [<a href="#rid134">134</a>]. Furthermore, the very early supplementation of newborns' diet with gluten (&lt;3 months) showed an increased risk for islet autoantibodies, which precede type 1 diabetes mellitus [<a href="#rid135">135</a>]. Thus, larger and prospective clinical studies are required to clarify the relationship between celiac disease, type 1 diabetes, and other secondary autoimmunities. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thyroid disease</strong> – There is an increased incidence of autoimmune thyroid disease among patients with celiac disease [<a href="#rid136">136,137</a>]. Hypothyroidism is more frequent than hyperthyroidism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atopic dermatitis</strong> – Patients with celiac disease (and their families) may also be more likely to have atopic dermatitis compared with the general population, although the prevalence of other allergies is not increased [<a href="#rid138">138</a>].</p><p></p><p class="headingAnchor" id="H2046557575"><span class="h2">Gastrointestinal disease</span></p><p class="headingAnchor" id="H23610960"><span class="h3">Gastroesophageal reflux disease</span><span class="headingEndMark"> — </span>An association of celiac disease with gastroesophageal reflux disease (GERD) has been reported. In a study of 133 patients with celiac disease and 70 healthy controls, patients with celiac disease had significantly higher GERD symptom scores when compared with controls [<a href="#rid139">139</a>]. Prior to treatment, 30 percent of patients with celiac disease reported moderate to severe symptoms compared with 6 percent of controls. Fifteen percent of patients with atypical or silent cases of celiac disease reported moderate to severe GERD. Three months after initiating a gluten-free diet, GERD symptom scores in patients with celiac disease were comparable to those in the healthy controls.</p><p class="headingAnchor" id="H109822400"><span class="h3">Eosinophilic esophagitis</span><span class="headingEndMark"> — </span>The incidence of eosinophilic esophagitis is increased in both children and adults with celiac disease (age-adjusted and sex-adjusted standardized incidence ratio [SIR] 16.0, 95% CI 8.7-25.5) [<a href="#rid140">140-144</a>].</p><p class="headingAnchor" id="H1190789757"><span class="h3">Inflammatory bowel disease</span><span class="headingEndMark"> — </span>Several case series have demonstrated an association between celiac disease and inflammatory bowel disease (IBD), more frequently with ulcerative colitis than Crohn disease [<a href="#rid145">145,146</a>]. In one case-control study, the risk of IBD in patients with celiac disease was elevated 10-fold, while the risk of celiac disease in patients with IBD was comparable to controls [<a href="#rid147">147</a>]. Of note, two independent studies have found a common proinflammatory polymorphism of the IL-23 receptor gene in both ulcerative colitis and celiac disease [<a href="#rid148">148,149</a>]. First-degree relatives of patients with celiac disease may also be at a fivefold increased risk of developing ulcerative colitis as compared with the general population [<a href="#rid150">150</a>]. In one case-control study that included 51 patients with coexisting IBD and celiac disease and 102 IBD controls, patients with ulcerative colitis and coexisting celiac disease were more likely to have pancolitis as compared with patients with ulcerative colitis alone (odds ratio [OR] 3.3, 95% CI 1.05-21.5) [<a href="#rid151">151</a>]. However, among patients with Crohn disease, there were no phenotypic differences based on the presence of coexisting celiac disease.</p><p class="headingAnchor" id="H1563671551"><span class="h3">Microscopic colitis</span><span class="headingEndMark"> — </span>Patients with celiac disease have an increased risk of microscopic colitis. In a large cohort study of 1009 patients with celiac disease, 44 (4.3 percent) were diagnosed with microscopic colitis, corresponding to a 72-fold increased risk of microscopic colitis in patients with celiac disease, as compared with the general population [<a href="#rid152">152</a>]. (See  <a class="medical medical_review" href="/z/d/html/4071.html" rel="external">"Microscopic (lymphocytic and collagenous) colitis: Clinical manifestations, diagnosis, and management", section on 'Associated conditions'</a>.)</p><p class="headingAnchor" id="H1572935728"><span class="h3">Liver disease</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elevated aminotransferase</strong> – Celiac disease may be associated with nonspecific mild to moderate chronic elevation in serum aminotransferase levels in 15 to 55 percent of patients (alanine aminotransferase is usually slightly greater than aspartate aminotransferase [<a href="#rid153">153,154</a>]). A meta-analysis found that in patients with cryptogenic elevations in aminotransferases, celiac serologies were positive in 6 percent and duodenal biopsies suggested celiac disease in 4 percent [<a href="#rid155">155</a>]. In addition, abnormal serum transaminases were detected in 27 percent of patients with newly diagnosed celiac disease. Serum transaminases normalized in 63 to 90 percent of patients within a year of initiating a gluten-free diet. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cholestatic and autoimmune liver disease</strong> – Celiac disease has been associated with primary biliary cirrhosis (PBC) [<a href="#rid156">156</a>]. Two large studies suggested a prevalence of 6 to 11 percent in patients with PBC, although these may be overestimates [<a href="#rid157">157,158</a>]. (See  <a class="medical medical_review" href="/z/d/html/3606.html" rel="external">"Evaluation and treatment of low bone mass in primary biliary cholangitis (primary biliary cirrhosis)"</a>.)</p><p></p><p>Celiac disease has also been associated with other causes of liver disease [<a href="#rid156">156,159,160</a>]. One study evaluated the risk of liver disease in 13,818 patients with celiac disease from 1964 to 2003, with 66,584 age- and sex-matched controls [<a href="#rid160">160</a>]. Celiac disease was associated with an increased risk of acute hepatitis, chronic hepatitis, and primary sclerosing cholangitis. Adjustment for socioeconomic index or diabetes mellitus had no notable effect on the risk estimates. In addition, prior liver disease was associated with a statistically significant four- to six-fold increased risk of later celiac disease.</p><p class="headingAnchor" id="H2966690546"><span class="h3">Pancreatitis</span><span class="headingEndMark"> — </span>Large database studies have described an increased risk of pancreatitis (both acute and chronic) in patients with celiac disease [<a href="#rid161">161,162</a>]. Further studies are needed to clarify the strength of the association and potential mechanisms that underlie it. </p><p class="headingAnchor" id="H33"><span class="h2">Menstrual and reproductive issues</span><span class="headingEndMark"> — </span>On a population basis, women with celiac disease, most of them on a gluten-free diet, have similar overall fertility to the general female population [<a href="#rid163">163,164</a>]. However, women with untreated celiac disease may have later age of menarche, earlier menopause, secondary amenorrhea, recurrent miscarriage, spontaneous abortion, preterm delivery, and low birth weight [<a href="#rid164">164-174</a>]. </p><p>Male infertility, characterized by abnormalities in sperm motility and morphology as well as a biochemical picture of androgen resistance (high serum testosterone and high luteinizing hormone [LH] concentrations), has been reported in celiac disease [<a href="#rid175">175,176</a>]. In one study of 41 men with celiac disease and high testosterone and LH concentrations, dietary modification led to normalization of the biochemical abnormalities [<a href="#rid176">176</a>]. (See  <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">"Causes of male infertility"</a>.)</p><p class="headingAnchor" id="H475718819"><span class="h2">Idiopathic pulmonary hemosiderosis</span><span class="headingEndMark"> — </span>Coexistence of celiac disease and idiopathic pulmonary hemosiderosis, also known as Lane-Hamilton syndrome, has been reported in a number of cases, and introduction of a gluten-free diet has been associated with remission of pulmonary symptoms in several patients. (See  <a class="medical medical_review" href="/z/d/html/4318.html" rel="external">"Idiopathic pulmonary hemosiderosis"</a>.)</p><p class="headingAnchor" id="H3258229076"><span class="h2">Cardiovascular disease</span><span class="headingEndMark"> — </span>Celiac disease, which is often clinically unsuspected, accounts for as many as 5 percent of patients with autoimmune myocarditis or idiopathic dilated cardiomyopathy [<a href="#rid177">177,178</a>]. In one study of nine such patients, none had classic gastrointestinal symptoms of celiac disease (recurrent abdominal pain, diarrhea, and weight loss), but all had iron deficiency anemia refractory to oral iron replacement [<a href="#rid177">177</a>]. Cardiac function improved following a gluten-free diet with or without immunosuppressive therapy. Patients with celiac disease may also be at increased risk for ischemic heart disease [<a href="#rid179">179-183</a>]. (See  <a class="medical medical_review" href="/z/d/html/4933.html" rel="external">"Myocarditis: Causes and pathogenesis", section on 'Celiac disease'</a>.)</p><p class="headingAnchor" id="H2603445093"><span class="h2">Kidney disease</span><span class="headingEndMark"> — </span>Glomerular IgA deposition is common, occurring in as many as one-third of patients. The great majority of affected patients have no clinical manifestations of kidney disease, perhaps because there is no associated activation of complement. (See  <a class="medical medical_review" href="/z/d/html/3095.html" rel="external">"IgA nephropathy: Pathogenesis"</a>.)</p><p class="headingAnchor" id="H1925376184"><span class="h1">PROGNOSIS</span></p><p class="headingAnchor" id="H2896691589"><span class="h2">Cancer risk</span><span class="headingEndMark"> — </span>Patients with celiac disease are at increased risk for lymphoma and gastrointestinal cancer. Whether the degree of compliance with a gluten-free diet influences the rates of cancers is uncertain [<a href="#rid184">184,185</a>]. The increase in cancer risk in patients with celiac disease is illustrated in the following studies:</p><p class="bulletIndent1"><span class="glyph">●</span>One of the largest population-based studies to address cancer risk in patients with celiac disease included 12,000 patients with celiac disease or dermatitis herpetiformis [<a href="#rid186">186</a>]. Cancer was diagnosed in 249 patients during follow-up (standardized incidence ratio [SIR] 1.3, 95% CI 1.2-1.5), suggesting that the overall increase in cancer risk was modest. The risk of cancer was not increased in children or adolescents. The most common malignancy was lymphoma (SIR 5.9), which accounted for 18 percent of all cancers  (<a class="graphic graphic_diagnosticimage graphicRef67338" href="/z/d/graphic/67338.html" rel="external">image 1</a>). The risk of other digestive tract cancers was also increased, including oropharyngeal (mostly esophageal squamous cell), small intestinal adenocarcinoma, colorectal, and hepatocellular. In contrast, there was a significantly reduced risk of breast cancer. The risk declined with increasing length of follow-up. (See  <a class="medical medical_review" href="/z/d/html/4743.html" rel="external">"Clinical presentation and diagnosis of primary gastrointestinal lymphomas"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another large cohort study that evaluated the risk of gastrointestinal (GI) cancers in 28,882 patients with celiac disease (villous atrophy, Marsh score = 3), 12,860 with mild inflammation (Marsh score 1 to 2), and 3705 individuals with potential celiac disease (normal mucosa but positive serology), the risk of incident GI cancers was increased in all three groups in the first year of diagnosis (hazard ratio [HR] 5.95, 9.13, 8.10, respectively) [<a href="#rid187">187</a>]. Although the high incident cancer risk in the first year of diagnosis may be due to ascertainment bias, after the first year of diagnosis, the site-specific risk for small intestinal cancer and hepatocellular carcinoma was increased in patients with celiac disease (HR 2.22 and 1.78) and inflammation (HR 2.49 and 2.17). There was an increased risk of lymphoproliferative malignancy in patients with villous atrophy (HR 2.82) compared with patients with intestinal inflammation without villous atrophy (HR 1.81), but not in individuals with normal mucosa but positive serology celiac disease (HR 0.97) [<a href="#rid188">188</a>]. This risk of lymphoma but not solid tumors remained increased for five years or more after diagnosis despite adherence to a gluten-free diet. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a retrospective study that included 48,119 individuals with celiac disease and 239,249 controls, the risk of small bowel adenomas and adenocarcinoma was increased in individuals with celiac disease (HR 5.73 [95% CI, 3.70–8.88] and 3.05 [95% CI, 1.86–4.99], respectively), however, the absolute risk of small bowel adenocarcinoma was low (5 per 10,000 celiac patients over 10 years) [<a href="#rid189">189</a>]. Individuals with celiac disease with mucosal healing had lower rates of small bowel adenocarcinoma, as compared to those with persistent villous atrophy, but the differences were not statistically significant (0.01 versus 0.18 percent, HR 0.18 [95% CI 0.02-1.61]). The risk of carcinoids was not increased in individuals with celiac disease. </p><p></p><p class="headingAnchor" id="H3025041542"><span class="h2">Mortality</span><span class="headingEndMark"> — </span>A number of observational studies have noted a small absolute increase in overall mortality in patients with celiac disease compared with the general population [<a href="#rid127">127,179,184,186,190-196</a>]. The magnitude of mortality risk and its relation to small bowel histopathology was evaluated in a retrospective cohort study that included approximately 29,000 individuals with celiac disease (Marsh stage 3: villous atrophy), 13,000 individuals with only inflammation on biopsy (Marsh stage 1 to 2), and 3700 individuals with normal mucosal histology (Marsh 0), but positive celiac disease serology [<a href="#rid179">179</a>]. There was a significant absolute increase in mortality in all three groups (2.9, 10.8, and 1.7 per 1000 person-years, respectively). The higher absolute mortality among patients with inflammation is partly explained by their older age at study entry. The increase in mortality was largely due to cardiovascular disease and malignancy.</p><p class="headingAnchor" id="H1160958645"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113964.html" rel="external">"Society guideline links: Celiac disease"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/130048.html" rel="external">"Society guideline links: Dermatitis herpetiformis"</a>.)</p><p class="headingAnchor" id="H1564713336"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15378.html" rel="external">"Patient education: Celiac disease (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/1999.html" rel="external">"Patient education: Celiac disease in adults (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3576292915"><span class="h1">PATIENT PERSPECTIVE TOPIC</span><span class="headingEndMark"> — </span>Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See  <a class="medical medical_review" href="/z/d/html/132664.html" rel="external">"Patient perspective: Celiac disease"</a>.)</p><p class="headingAnchor" id="H23610989"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Celiac disease is not limited to individuals ethnically derived from European populations and has increasingly been found in populations of Northern Africa, the Middle East, India, and Northern China. The estimated global prevalence of celiac disease based on serologic studies is approximately 1 percent, and locally can be well above 1 percent. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>High-risk groups </strong>– First- and second-degree relatives of patients with celiac disease are at increased risk for celiac disease. Other high-risk groups include patients with one of the following (see <a class="local">'High risk groups'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Type 1 diabetes</p><p class="bulletIndent2"><span class="glyph">•</span>Autoimmune thyroiditis</p><p class="bulletIndent2"><span class="glyph">•</span>Several other autoimmune diseases </p><p class="bulletIndent2"><span class="glyph">•</span>Down and Turner syndromes</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Celiac disease is an immune disorder triggered by an environmental agent (the gluten component of wheat or related cereals) in genetically predisposed individuals. The genetic basis of celiac disease is supported by the frequent intrafamilial occurrence and the remarkably close association with the human leukocyte antigen (HLA) DR3-DQ2 and/or DR4-DQ8 gene locus. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Patients with celiac disease may present with classic symptoms related to malabsorption, including diarrhea, steatorrhea, weight loss, and nutrient or vitamin deficiencies. However, the majority of patients with celiac disease exhibit only minor gastrointestinal complaints, have extraintestinal manifestations, or are asymptomatic. (See <a class="local">'Gastrointestinal manifestations'</a> above and <a class="local">'Clinical manifestations'</a> above and <a class="local">'Symptomatic disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Associated conditions </strong>–<strong> </strong>Celiac disease is frequently associated with dermatitis herpetiformis, selective IgA deficiency, and other conditions which have autoimmune features such as type 1 diabetes mellitus, thyroid disease, and other autoimmune diseases. (See <a class="local">'Associated conditions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cancer risk</strong> – Patients with untreated celiac disease are at increased risk for lymphoma and gastrointestinal cancer. It remains unclear if early detection of celiac disease, the prior duration and severity of active celiac disease, or the degree of compliance with a gluten-free diet influence the rates of the associated cancers. (See <a class="local">'Prognosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kagnoff MF. Celiac disease. A gastrointestinal disease with environmental, genetic, and immunologic components. Gastroenterol Clin North Am 1992; 21:405.</a></li><li><a class="nounderline abstract_t">Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119:234.</a></li><li><a class="nounderline abstract_t">Al-Toma A, Goerres MS, Meijer JW, et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 2006; 4:315.</a></li><li><a class="nounderline abstract_t">Pietzak MM, Schofield TC, McGinniss MJ, Nakamura RM. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol 2009; 7:966.</a></li><li><a class="nounderline abstract_t">Liu E, Lee HS, Aronsson CA, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med 2014; 371:42.</a></li><li><a class="nounderline abstract_t">Petronzelli F, Bonamico M, Ferrante P, et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997; 61:307.</a></li><li><a class="nounderline abstract_t">Houlston RS, Ford D. Genetics of coeliac disease. QJM 1996; 89:737.</a></li><li><a class="nounderline abstract_t">Houlston RS, Tomlinson IP, Ford D, et al. Linkage analysis of candidate regions for coeliac disease genes. Hum Mol Genet 1997; 6:1335.</a></li><li><a class="nounderline abstract_t">Greco L, Corazza G, Babron MC, et al. Genome search in celiac disease. Am J Hum Genet 1998; 62:669.</a></li><li><a class="nounderline abstract_t">Romanos J, van Diemen CC, Nolte IM, et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009; 137:834.</a></li><li><a class="nounderline abstract_t">Trynka G, Zhernakova A, Romanos J, et al. Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 2009; 58:1078.</a></li><li><a class="nounderline abstract_t">Verdu EF, Schuppan D. Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment. Gastroenterology 2021; 161:1395.</a></li><li><a class="nounderline abstract_t">Kahaly GJ, Frommer L, Schuppan D. Celiac disease and endocrine autoimmunity - the genetic link. Autoimmun Rev 2018; 17:1169.</a></li><li><a class="nounderline abstract_t">Kahaly GJ, Frommer L, Schuppan D. Celiac Disease and Glandular Autoimmunity. Nutrients 2018; 10.</a></li><li><a class="nounderline abstract_t">Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008; 40:395.</a></li><li><a class="nounderline abstract_t">Molberg O, Mcadam SN, Körner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4:713.</a></li><li><a class="nounderline abstract_t">Schuppan D, Dieterich W, Riecken EO. Exposing gliadin as a tasty food for lymphocytes. Nat Med 1998; 4:666.</a></li><li><a class="nounderline abstract_t">van de Wal Y, Kooy Y, van Veelen P, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161:1585.</a></li><li><a class="nounderline abstract_t">Shan L, Molberg Ø, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297:2275.</a></li><li><a class="nounderline abstract_t">Matysiak-Budnik T, Candalh C, Dugave C, et al. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 2003; 125:696.</a></li><li><a class="nounderline abstract_t">Schuppan D, Mäki M, Lundin KEA, et al. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease. N Engl J Med 2021; 385:35.</a></li><li><a class="nounderline abstract_t">Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008; 205:143.</a></li><li><a class="nounderline abstract_t">Lammers KM, Lu R, Brownley J, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008; 135:194.</a></li><li><a class="nounderline abstract_t">Halttunen T, Mäki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999; 116:566.</a></li><li><a class="nounderline abstract_t">Esposito C, Paparo F, Caputo I, et al. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut 2002; 51:177.</a></li><li><a class="nounderline abstract_t">Dieterich W, Trapp D, Esslinger B, et al. Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Gut 2003; 52:1562.</a></li><li><a class="nounderline abstract_t">Esposito C, Paparo F, Caputo I, et al. Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol 2003; 98:1813.</a></li><li><a class="nounderline abstract_t">Forsberg G, Hernell O, Melgar S, et al. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 2002; 123:667.</a></li><li><a class="nounderline abstract_t">Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998; 114:471.</a></li><li><a class="nounderline abstract_t">Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med 2006; 130:1020.</a></li><li><a class="nounderline abstract_t">Fritscher-Ravens A, Pflaum T, Mösinger M, et al. Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E. Gastroenterology 2019; 157:109.</a></li><li><a class="nounderline abstract_t">Abadie V, Kim SM, Lejeune T, et al. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease. Nature 2020; 578:600.</a></li><li><a class="nounderline abstract_t">Kivelä L, Caminero A, Leffler DA, et al. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol 2021; 18:181.</a></li><li><a class="nounderline abstract_t">Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003; 362:30.</a></li><li><a class="nounderline abstract_t">Schuppan D, Esslinger B, Dieterich W. Innate immunity and coeliac disease. Lancet 2003; 362:3.</a></li><li><a class="nounderline abstract_t">Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev 2005; 206:219.</a></li><li><a class="nounderline abstract_t">Londei M, Ciacci C, Ricciardelli I, et al. Gliadin as a stimulator of innate responses in celiac disease. Mol Immunol 2005; 42:913.</a></li><li><a class="nounderline abstract_t">Nikulina M, Habich C, Flohé SB, et al. Wheat gluten causes dendritic cell maturation and chemokine secretion. J Immunol 2004; 173:1925.</a></li><li><a class="nounderline abstract_t">Palová-Jelínková L, Rozková D, Pecharová B, et al. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J Immunol 2005; 175:7038.</a></li><li><a class="nounderline abstract_t">Cinova J, Palová-Jelínková L, Smythies LE, et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol 2007; 27:201.</a></li><li><a class="nounderline abstract_t">Junker Y, Zeissig S, Kim SJ, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 2012; 209:2395.</a></li><li><a class="nounderline abstract_t">Carroccio A, Mansueto P, Soresi M, et al. Wheat Consumption Leads to Immune Activation and Symptom Worsening in Patients with Familial Mediterranean Fever: A Pilot Randomized Trial. Nutrients 2020; 12.</a></li><li><a class="nounderline abstract_t">Pickert G, Wirtz S, Matzner J, et al. Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis. Gastroenterology 2020; 159:257.</a></li><li><a class="nounderline abstract_t">Bellinghausen I, Weigmann B, Zevallos V, et al. Wheat amylase-trypsin inhibitors exacerbate intestinal and airway allergic immune responses in humanized mice. J Allergy Clin Immunol 2019; 143:201.</a></li><li><a class="nounderline abstract_t">Zevallos VF, Raker V, Tenzer S, et al. Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells. Gastroenterology 2017; 152:1100.</a></li><li><a class="nounderline abstract_t">Catassi C, Alaedini A, Bojarski C, et al. The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update. Nutrients 2017; 9.</a></li><li class="breakAll">Schuppan D, Gisbert-Schuppan K. Wheat syndromes: How wheat, gluten and ATI cause inflammation, IBS, and autoimmunity, Springer Nature, Basel 2019. p.1.</li><li><a class="nounderline abstract_t">Sher KS, Fraser RC, Wicks AC, Mayberry JF. High risk of coeliac disease in Punjabis. Epidemiological study in the south Asian and European populations of Leicestershire. Digestion 1993; 54:178.</a></li><li><a class="nounderline abstract_t">Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012; 107:1538.</a></li><li><a class="nounderline abstract_t">Choung RS, Larson SA, Khaleghi S, et al. Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-Based Study. Gastroenterology 2017; 152:830.</a></li><li><a class="nounderline abstract_t">Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012; 18:6036.</a></li><li><a class="nounderline abstract_t">Singh P, Arora A, Strand TA, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2018; 16:823.</a></li><li><a class="nounderline abstract_t">Cataldo F, Montalto G. Celiac disease in the developing countries: a new and challenging public health problem. World J Gastroenterol 2007; 13:2153.</a></li><li><a class="nounderline abstract_t">Catassi C, Fabiani E, Rätsch IM, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl 1996; 412:29.</a></li><li><a class="nounderline abstract_t">Pittschieler K, Ladinser B. Coeliac disease: screened by a new strategy. Acta Paediatr Suppl 1996; 412:42.</a></li><li><a class="nounderline abstract_t">Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003; 348:2517.</a></li><li><a class="nounderline abstract_t">Grodzinsky E. Screening for coeliac disease in apparently healthy blood donors. Acta Paediatr Suppl 1996; 412:36.</a></li><li><a class="nounderline abstract_t">Tommasini A, Not T, Kiren V, et al. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 2004; 89:512.</a></li><li><a class="nounderline abstract_t">Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163:286.</a></li><li><a class="nounderline abstract_t">Catassi C, Kryszak D, Louis-Jacques O, et al. Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007; 102:1454.</a></li><li><a class="nounderline abstract_t">Greco L, Percopo S. The coeliac disease task force " Free from Gluten," " Improved knowledge to cure coeliac disease". Acta Paediatr Suppl 1996; 412:25.</a></li><li><a class="nounderline abstract_t">Johnston SD, Watson RG, McMillan SA, et al. Preliminary results from follow-up of a large-scale population survey of antibodies to gliadin, reticulin and endomysium. Acta Paediatr Suppl 1996; 412:61.</a></li><li><a class="nounderline abstract_t">Kim HS, Patel KG, Orosz E, et al. Time Trends in the Prevalence of Celiac Disease and Gluten-Free Diet in the US Population: Results From the National Health and Nutrition Examination Surveys 2009-2014. JAMA Intern Med 2016; 176:1716.</a></li><li><a class="nounderline abstract_t">Gatti S, Lionetti E, Balanzoni L, et al. Increased Prevalence of Celiac Disease in School-age Children in Italy. Clin Gastroenterol Hepatol 2020; 18:596.</a></li><li><a class="nounderline abstract_t">Singh P, Arora S, Lal S, et al. Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2015; 110:1539.</a></li><li><a class="nounderline abstract_t">RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC Jr. Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology 1960; 38:28.</a></li><li><a class="nounderline abstract_t">Troncone R, Greco L, Mayer M, et al. Latent and potential coeliac disease. Acta Paediatr Suppl 1996; 412:10.</a></li><li><a class="nounderline abstract_t">Matysiak-Budnik T, Malamut G, de Serre NP, et al. Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 2007; 56:1379.</a></li><li><a class="nounderline abstract_t">Taavela J, Koskinen O, Huhtala H, et al. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One 2013; 8:e76163.</a></li><li><a class="nounderline abstract_t">Gopal P, McKenna BJ. The collagenous gastroenteritides: similarities and differences. Arch Pathol Lab Med 2010; 134:1485.</a></li><li><a class="nounderline abstract_t">West J, Logan RF, Hill PG, Khaw KT. The iceberg of celiac disease: what is below the waterline? Clin Gastroenterol Hepatol 2007; 5:59.</a></li><li><a class="nounderline abstract_t">Taavela J, Kurppa K, Collin P, et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol 2013; 11:166.</a></li><li><a class="nounderline abstract_t">Jamma S, Rubio-Tapia A, Kelly CP, et al. Celiac crisis is a rare but serious complication of celiac disease in adults. Clin Gastroenterol Hepatol 2010; 8:587.</a></li><li><a class="nounderline abstract_t">Zanini B, Caselani F, Magni A, et al. Celiac disease with mild enteropathy is not mild disease. Clin Gastroenterol Hepatol 2013; 11:253.</a></li><li><a class="nounderline abstract_t">Fry L, Seah PP, McMinn RM, Hoffbrand AV. Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J 1972; 3:371.</a></li><li><a class="nounderline abstract_t">Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102:330.</a></li><li><a class="nounderline abstract_t">Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 1995; 9:273.</a></li><li><a class="nounderline abstract_t">Ferguson A, Arranz E, O'Mahony S. Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential. Gut 1993; 34:150.</a></li><li><a class="nounderline abstract_t">Pastore L, Lo Muzio L, Serpico R. Atrophic glossitis leading to the diagnosis of celiac disease. N Engl J Med 2007; 356:2547.</a></li><li><a class="nounderline abstract_t">Lähteenoja H, Toivanen A, Viander M, et al. Oral mucosal changes in coeliac patients on a gluten-free diet. Eur J Oral Sci 1998; 106:899.</a></li><li><a class="nounderline abstract_t">Kemppainen T, Kröger H, Janatuinen E, et al. Osteoporosis in adult patients with celiac disease. Bone 1999; 24:249.</a></li><li><a class="nounderline abstract_t">Shaker JL, Brickner RC, Findling JW, et al. Hypocalcemia and skeletal disease as presenting features of celiac disease. Arch Intern Med 1997; 157:1013.</a></li><li><a class="nounderline abstract_t">Mustalahti K, Collin P, Sievänen H, et al. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet 1999; 354:744.</a></li><li><a class="nounderline abstract_t">Bottaro G, Cataldo F, Rotolo N, et al. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol 1999; 94:691.</a></li><li><a class="nounderline abstract_t">Selby PL, Davies M, Adams JE, Mawer EB. Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res 1999; 14:652.</a></li><li><a class="nounderline abstract_t">Fickling WE, McFarlane XA, Bhalla AK, Robertson DA. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med J 2001; 77:33.</a></li><li><a class="nounderline abstract_t">Mora S, Weber G, Barera G, et al. Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr 1993; 57:224.</a></li><li><a class="nounderline abstract_t">West J, Logan RF, Card TR, et al. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 2003; 125:429.</a></li><li><a class="nounderline abstract_t">Lubrano E, Ciacci C, Ames PR, et al. The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol 1996; 35:1314.</a></li><li><a class="nounderline abstract_t">Carroccio A, Iannitto E, Cavataio F, et al. Sideropenic anemia and celiac disease: one study, two points of view. Dig Dis Sci 1998; 43:673.</a></li><li><a class="nounderline abstract_t">Fine KD. The prevalence of occult gastrointestinal bleeding in celiac sprue. N Engl J Med 1996; 334:1163.</a></li><li><a class="nounderline abstract_t">Murray JA, McLachlan S, Adams PC, et al. Association between celiac disease and iron deficiency in Caucasians, but not non-Caucasians. Clin Gastroenterol Hepatol 2013; 11:808.</a></li><li><a class="nounderline abstract_t">Ackerman Z, Eliakim R, Stalnikowicz R, Rachmilewitz D. Role of small bowel biopsy in the endoscopic evaluation of adults with iron deficiency anemia. Am J Gastroenterol 1996; 91:2099.</a></li><li><a class="nounderline abstract_t">Carroccio A, Giannitrapani L, Di Prima L, et al. Extreme thrombocytosis as a sign of coeliac disease in the elderly: case report. Eur J Gastroenterol Hepatol 2002; 14:897.</a></li><li><a class="nounderline abstract_t">Schmitz F, Herzig KH, Stüber E, et al. On the pathogenesis and clinical course of mesenteric lymph node cavitation and hyposplenism in coeliac disease. Int J Colorectal Dis 2002; 17:192.</a></li><li><a class="nounderline abstract_t">Johnston SD, Robinson J. Fatal pneumococcal septicaemia in a coeliac patient. Eur J Gastroenterol Hepatol 1998; 10:353.</a></li><li><a class="nounderline abstract_t">McKinley M, Leibowitz S, Bronzo R, et al. Appropriate response to pneumococcal vaccine in celiac sprue. J Clin Gastroenterol 1995; 20:113.</a></li><li><a class="nounderline abstract_t">Cicarelli G, Della Rocca G, Amboni M, et al. Clinical and neurological abnormalities in adult celiac disease. Neurol Sci 2003; 24:311.</a></li><li><a class="nounderline abstract_t">Chin RL, Sander HW, Brannagan TH, et al. Celiac neuropathy. Neurology 2003; 60:1581.</a></li><li><a class="nounderline abstract_t">Addolorato G, Stefanini GF, Capristo E, et al. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality "trait" or a reactive illness? Hepatogastroenterology 1996; 43:1513.</a></li><li><a class="nounderline abstract_t">Hadjivassiliou M, Chattopadhyay AK, Davies-Jones GA, et al. Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry 1997; 63:770.</a></li><li><a class="nounderline abstract_t">Cronin CC, Jackson LM, Feighery C, et al. Coeliac disease and epilepsy. QJM 1998; 91:303.</a></li><li><a class="nounderline abstract_t">Hu WT, Murray JA, Greenaway MC, et al. Cognitive impairment and celiac disease. Arch Neurol 2006; 63:1440.</a></li><li><a class="nounderline abstract_t">Hadjivassiliou M, Gibson A, Davies-Jones GA, et al. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996; 347:369.</a></li><li><a class="nounderline abstract_t">Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352:1582.</a></li><li><a class="nounderline abstract_t">Hadjivassiliou M, Grünewald RA, Lawden M, et al. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 2001; 56:385.</a></li><li><a class="nounderline abstract_t">Addolorato G, Di Giuda D, De Rossi G, et al. Regional cerebral hypoperfusion in patients with celiac disease. Am J Med 2004; 116:312.</a></li><li><a class="nounderline abstract_t">Hadjivassiliou M, Mäki M, Sanders DS, et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 2006; 66:373.</a></li><li><a class="nounderline abstract_t">Banerji NK, Hurwitz LJ. Neurological manifestations in adult steatorrhoea (probable Gluten enteropathy). J Neurol Sci 1971; 14:125.</a></li><li><a class="nounderline abstract_t">Kaplan JG, Pack D, Horoupian D, et al. Distal axonopathy associated with chronic gluten enteropathy: a treatable disorder. Neurology 1988; 38:642.</a></li><li><a class="nounderline abstract_t">Usai P, Usai Satta P, Lai M, et al. Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest 1997; 27:1009.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, Zingone F, Tomson T, et al. Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study. Neurology 2012; 78:1401.</a></li><li><a class="nounderline abstract_t">Dimitrova AK, Ungaro RC, Lebwohl B, et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache 2013; 53:344.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, Reutfors J, Osby U, et al. Coeliac disease and risk of mood disorders--a general population-based cohort study. J Affect Disord 2007; 99:117.</a></li><li><a class="nounderline abstract_t">Garud S, Leffler D, Dennis M, et al. Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States. Aliment Pharmacol Ther 2009; 29:898.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, Olsson T, Ekbom A, Montgomery SM. A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment Pharmacol Ther 2007; 25:1317.</a></li><li><a class="nounderline abstract_t">Luostarinen L, Himanen SL, Luostarinen M, et al. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry 2003; 74:490.</a></li><li><a class="nounderline abstract_t">Meini A, Pillan NM, Villanacci V, et al. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann Allergy Asthma Immunol 1996; 77:333.</a></li><li><a class="nounderline abstract_t">Cataldo F, Marino V, Bottaro G, et al. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997; 131:306.</a></li><li><a class="nounderline abstract_t">Schuppan D, Hahn EG. Celiac disease and its link to type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001; 14 Suppl 1:597.</a></li><li><a class="nounderline abstract_t">Acerini CL, Ahmed ML, Ross KM, et al. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet. Diabet Med 1998; 15:38.</a></li><li><a class="nounderline abstract_t">Cronin CC, Feighery A, Ferriss JB, et al. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol 1997; 92:2210.</a></li><li><a class="nounderline abstract_t">Talal AH, Murray JA, Goeken JA, Sivitz WI. Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing. Am J Gastroenterol 1997; 92:1280.</a></li><li><a class="nounderline abstract_t">Seissler J, Schott M, Boms S, et al. Autoantibodies to human tissue transgutaminase identify silent coeliac disease in Type I diabetes. Diabetologia 1999; 42:1440.</a></li><li><a class="nounderline abstract_t">Kordonouri O, Dieterich W, Schuppan D, et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus. Diabet Med 2000; 17:441.</a></li><li><a class="nounderline abstract_t">Hummel M, Bonifacio E, Stern M, et al. Development of celiac disease-associated antibodies in offspring of parents with type I diabetes. Diabetologia 2000; 43:1005.</a></li><li><a class="nounderline abstract_t">Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358:356.</a></li><li><a class="nounderline abstract_t">Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359:2767.</a></li><li><a class="nounderline abstract_t">Bao F, Yu L, Babu S, et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999; 13:143.</a></li><li><a class="nounderline abstract_t">Galli-Tsinopoulou A, Nousia-Arvanitakis S, Dracoulacos D, et al. Autoantibodies predicting diabetes mellitus type I in celiac disease. Horm Res 1999; 52:119.</a></li><li><a class="nounderline abstract_t">Saukkonen T, Savilahti E, Reijonen H, et al. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabet Med 1996; 13:464.</a></li><li><a class="nounderline abstract_t">Westman E, Ambler GR, Royle M, et al. Children with coeliac disease and insulin dependent diabetes mellitus--growth, diabetes control and dietary intake. J Pediatr Endocrinol Metab 1999; 12:433.</a></li><li><a class="nounderline abstract_t">Meddings JB, Jarand J, Urbanski SJ, et al. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 1999; 276:G951.</a></li><li><a class="nounderline abstract_t">Funda DP, Kaas A, Bock T, et al. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 1999; 15:323.</a></li><li><a class="nounderline abstract_t">Ziegler AG, Schmid S, Huber D, et al. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290:1721.</a></li><li><a class="nounderline abstract_t">Counsell CE, Taha A, Ruddell WS. Coeliac disease and autoimmune thyroid disease. Gut 1994; 35:844.</a></li><li><a class="nounderline abstract_t">Badenhoop K, Dieterich W, Segni M, et al. HLA DQ2 and/or DQ8 is associated with celiac disease-specific autoantibodies to tissue transglutaminase in families with thyroid autoimmunity. Am J Gastroenterol 2001; 96:1648.</a></li><li><a class="nounderline abstract_t">Ciacci C, Cavallaro R, Iovino P, et al. Allergy prevalence in adult celiac disease. J Allergy Clin Immunol 2004; 113:1199.</a></li><li><a class="nounderline abstract_t">Nachman F, Vázquez H, González A, et al. Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol 2011; 9:214.</a></li><li><a class="nounderline abstract_t">Thompson JS, Lebwohl B, Reilly NR, et al. Increased incidence of eosinophilic esophagitis in children and adults with celiac disease. J Clin Gastroenterol 2012; 46:e6.</a></li><li><a class="nounderline abstract_t">Verzegnassi F, Bua J, De Angelis P, et al. Eosinophilic oesophagitis and coeliac disease: is it just a casual association? Gut 2007; 56:1029.</a></li><li><a class="nounderline abstract_t">Quaglietta L, Coccorullo P, Miele E, et al. Eosinophilic oesophagitis and coeliac disease: is there an association? Aliment Pharmacol Ther 2007; 26:487.</a></li><li><a class="nounderline abstract_t">Ooi CY, Day AS, Jackson R, et al. Eosinophilic esophagitis in children with celiac disease. J Gastroenterol Hepatol 2008; 23:1144.</a></li><li><a class="nounderline abstract_t">Leslie C, Mews C, Charles A, Ravikumara M. Celiac disease and eosinophilic esophagitis: a true association. J Pediatr Gastroenterol Nutr 2010; 50:397.</a></li><li><a class="nounderline abstract_t">Breen EG, Coghlan G, Connolly EC, et al. Increased association of ulcerative colitis and coeliac disease. Ir J Med Sci 1987; 156:120.</a></li><li><a class="nounderline abstract_t">Falchuk KR, Falchuk ZM. Selective immunoglobulin a deficiency, ulcerative colitis, and gluten-sensitive enteropathy--a unique association. Gastroenterology 1975; 69:503.</a></li><li><a class="nounderline abstract_t">Leeds JS, Höroldt BS, Sidhu R, et al. Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls. Scand J Gastroenterol 2007; 42:1214.</a></li><li><a class="nounderline abstract_t">Einarsdottir E, Koskinen LL, Dukes E, et al. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet 2009; 10:8.</a></li><li><a class="nounderline abstract_t">Glas J, Stallhofer J, Ripke S, et al. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol 2009; 104:1737.</a></li><li><a class="nounderline abstract_t">Shah A, Mayberry JF, Williams G, et al. Epidemiological survey of coeliac disease and inflammatory bowel disease in first-degree relatives of coeliac patients. Q J Med 1990; 74:283.</a></li><li><a class="nounderline abstract_t">Oxford EC, Nguyen DD, Sauk J, et al. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol 2013; 108:1123.</a></li><li><a class="nounderline abstract_t">Green PH, Yang J, Cheng J, et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol 2009; 7:1210.</a></li><li><a class="nounderline abstract_t">Volta U, De Franceschi L, Lari F, et al. Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet 1998; 352:26.</a></li><li><a class="nounderline abstract_t">Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999; 29:654.</a></li><li><a class="nounderline abstract_t">Sainsbury A, Sanders DS, Ford AC. Meta-analysis: Coeliac disease and hypertransaminasaemia. Aliment Pharmacol Ther 2011; 34:33.</a></li><li><a class="nounderline abstract_t">Duggan JM, Duggan AE. Systematic review: the liver in coeliac disease. Aliment Pharmacol Ther 2005; 21:515.</a></li><li><a class="nounderline abstract_t">Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998; 42:120.</a></li><li><a class="nounderline abstract_t">Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol 1997; 25:328.</a></li><li><a class="nounderline abstract_t">Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease. Clin Gastroenterol Hepatol 2004; 2:107.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, Elfström P, Broomé U, et al. Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol 2007; 5:63.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, Montgomery SM, Ekbom A. Risk of pancreatitis in 14,000 individuals with celiac disease. Clin Gastroenterol Hepatol 2007; 5:1347.</a></li><li><a class="nounderline abstract_t">Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF. Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol 2012; 10:1136.</a></li><li><a class="nounderline abstract_t">Tata LJ, Card TR, Logan RF, et al. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology 2005; 128:849.</a></li><li><a class="nounderline abstract_t">Moleski SM, Lindenmeyer CC, Veloski JJ, et al. Increased rates of pregnancy complications in women with celiac disease. Ann Gastroenterol 2015; 28:236.</a></li><li><a class="nounderline abstract_t">Rujner J. [Age at menarche in girls with celiac disease]. Ginekol Pol 1999; 70:359.</a></li><li><a class="nounderline abstract_t">Ferguson R, Holmes GK, Cooke WT. Coeliac disease, fertility, and pregnancy. Scand J Gastroenterol 1982; 17:65.</a></li><li><a class="nounderline abstract_t">Gasbarrini A, Torre ES, Trivellini C, et al. Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Lancet 2000; 356:399.</a></li><li><a class="nounderline abstract_t">Kumar A, Meena M, Begum N, et al. Latent celiac disease in reproductive performance of women. Fertil Steril 2011; 95:922.</a></li><li><a class="nounderline abstract_t">Sher KS, Mayberry JF. Female fertility, obstetric and gynaecological history in coeliac disease: a case control study. Acta Paediatr Suppl 1996; 412:76.</a></li><li><a class="nounderline abstract_t">Meloni GF, Dessole S, Vargiu N, et al. The prevalence of coeliac disease in infertility. Hum Reprod 1999; 14:2759.</a></li><li><a class="nounderline abstract_t">Collin P, Vilska S, Heinonen PK, et al. Infertility and coeliac disease. Gut 1996; 39:382.</a></li><li><a class="nounderline abstract_t">Soni S, Badawy SZ. Celiac disease and its effect on human reproduction: a review. J Reprod Med 2010; 55:3.</a></li><li><a class="nounderline abstract_t">Kiefte-de Jong JC, Jaddoe VW, Uitterlinden AG, et al. Levels of antibodies against tissue transglutaminase during pregnancy are associated with reduced fetal weight and birth weight. Gastroenterology 2013; 144:726.</a></li><li><a class="nounderline abstract_t">Nørgård B, Fonager K, Sørensen HT, Olsen J. Birth outcomes of women with celiac disease: a nationwide historical cohort study. Am J Gastroenterol 1999; 94:2435.</a></li><li><a class="nounderline abstract_t">Sher KS, Jayanthi V, Probert CS, et al. Infertility, obstetric and gynaecological problems in coeliac sprue. Dig Dis 1994; 12:186.</a></li><li><a class="nounderline abstract_t">Farthing MJ, Rees LH, Edwards CR, Dawson AM. Male gonadal function in coeliac disease: 2. Sex hormones. Gut 1983; 24:127.</a></li><li><a class="nounderline abstract_t">Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation 2002; 105:2611.</a></li><li><a class="nounderline abstract_t">Curione M, Barbato M, De Biase L, et al. Prevalence of coeliac disease in idiopathic dilated cardiomyopathy. Lancet 1999; 354:222.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302:1171.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, James S, Askling J, et al. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation 2011; 123:483.</a></li><li><a class="nounderline abstract_t">Ludvigsson JF, de Faire U, Ekbom A, Montgomery SM. Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease. Heart 2007; 93:1111.</a></li><li><a class="nounderline abstract_t">Peters U, Askling J, Gridley G, et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163:1566.</a></li><li><a class="nounderline abstract_t">Wei L, Spiers E, Reynolds N, et al. The association between coeliac disease and cardiovascular disease. Aliment Pharmacol Ther 2008; 27:514.</a></li><li><a class="nounderline abstract_t">Green PH, Fleischauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med 2003; 115:191.</a></li><li><a class="nounderline abstract_t">Booth CC. History of celiac disease. BMJ 1989; 298:527.</a></li><li><a class="nounderline abstract_t">Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002; 123:1428.</a></li><li><a class="nounderline abstract_t">Elfström P, Granath F, Ye W, Ludvigsson JF. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol 2012; 10:30.</a></li><li><a class="nounderline abstract_t">Elfström P, Granath F, Ekström Smedby K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 2011; 103:436.</a></li><li><a class="nounderline abstract_t">Emilsson L, Semrad C, Lebwohl B, et al. Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease. Gastroenterology 2020; 159:1686.</a></li><li><a class="nounderline abstract_t">Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137:88.</a></li><li><a class="nounderline abstract_t">Logan RF, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology 1989; 97:265.</a></li><li><a class="nounderline abstract_t">Nielsen OH, Jacobsen O, Pedersen ER, et al. Non-tropical sprue. Malignant diseases and mortality rate. Scand J Gastroenterol 1985; 20:13.</a></li><li><a class="nounderline abstract_t">Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287:1413.</a></li><li><a class="nounderline abstract_t">Anderson LA, McMillan SA, Watson RG, et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity". World J Gastroenterol 2007; 13:146.</a></li><li><a class="nounderline abstract_t">Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20:769.</a></li><li><a class="nounderline abstract_t">Grainge MJ, West J, Solaymani-Dodaran M, et al. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2012; 35:730.</a></li></ol></div><div id="topicVersionRevision">Topic 4774 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1512049" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Celiac disease. A gastrointestinal disease with environmental, genetic, and immunologic components.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10889174" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Current concepts of celiac disease pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16527694" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19500688" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24988556" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Risk of pediatric celiac disease according to HLA haplotype and country.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9365784" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Genetic contribution of the HLA region to the familial clustering of coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8944229" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Genetics of coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9259281" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Linkage analysis of candidate regions for coeliac disease genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9497251" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Genome search in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19454285" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19240061" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34416277" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30316996" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Celiac disease and endocrine autoimmunity - the genetic link.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29941778" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Celiac Disease and Glandular Autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18311140" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Newly identified genetic risk variants for celiac disease related to the immune response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9623982" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9623970" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Exposing gliadin as a tasty food for lymphocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9712018" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12351792" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Structural basis for gluten intolerance in celiac sprue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12949716" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Alterations of the intestinal transport and processing of gliadin peptides in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34192430" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18166587" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18485912" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10029615" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12117875" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14570723" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12907337" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12198691" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9496937" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Abnormal intestinal intraepithelial lymphocytes in refractory sprue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16831028" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31100380" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32051586" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33219355" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Current and emerging therapies for coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12853196" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12853189" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Innate immunity and coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16048552" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Innate and adaptive immunity: the yin and yang of celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15829281" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Gliadin as a stimulator of innate responses in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15265926" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Wheat gluten causes dendritic cell maturation and chemokine secretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16272365" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Gliadin fragments induce phenotypic and functional maturation of human dendritic cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17260166" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Gliadin peptides activate blood monocytes from patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23209313" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32316660" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Wheat Consumption Leads to Immune Activation and Symptom Worsening in Patients with Familial Mediterranean Fever: A Pilot Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32251667" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29574077" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Wheat amylase-trypsin inhibitors exacerbate intestinal and airway allergic immune responses in humanized mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27993525" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29160841" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29160841" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8359561" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : High risk of coeliac disease in Punjabis. Epidemiological study in the south Asian and European populations of Leicestershire.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22850429" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The prevalence of celiac disease in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27916669" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23155333" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Celiac disease: prevalence, diagnosis, pathogenesis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29551598" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17465493" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Celiac disease in the developing countries: a new and challenging public health problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783752" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783755" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Coeliac disease: screened by a new strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12815137" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prevalence of Celiac disease among children in Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783753" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Screening for coeliac disease in apparently healthy blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15155392" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Mass screening for coeliac disease using antihuman transglutaminase antibody assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12578508" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17355413" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Detection of Celiac disease in primary care: a multicenter case-finding study in North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783751" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The coeliac disease task force " Free from Gluten," " Improved knowledge to cure coeliac disease".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783763" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Preliminary results from follow-up of a large-scale population survey of antibodies to gliadin, reticulin and endomysium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27598396" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Time Trends in the Prevalence of Celiac Disease and Gluten-Free Diet in the US Population: Results From the National Health and Nutrition Examination Surveys 2009-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31220637" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Increased Prevalence of Celiac Disease in School-age Children in Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26416192" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14439871" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783748" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Latent and potential coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17303598" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24146832" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20923305" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The collagenous gastroenteritides: similarities and differences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17234556" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The iceberg of celiac disease: what is below the waterline?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23063678" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20417725" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Celiac crisis is a rare but serious complication of celiac disease in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23022697" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Celiac disease with mild enteropathy is not mild disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5070159" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1727768" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7549028" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Morphology of the mucosal lesion in gluten sensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8432463" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17568041" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Atrophic glossitis leading to the diagnosis of celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9786318" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Oral mucosal changes in coeliac patients on a gluten-free diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10071918" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Osteoporosis in adult patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9140273" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Hypocalcemia and skeletal disease as presenting features of celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10475193" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Osteopenia in patients with clinically silent coeliac disease warrants screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086653" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10234588" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Bone loss in celiac disease is related to secondary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11123392" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The clinical impact of metabolic bone disease in coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8424392" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Effect of gluten-free diet on bone mineral content in growing patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12891545" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Fracture risk in people with celiac disease: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9010064" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : The arthritis of coeliac disease: prevalence and pattern in 200 adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9539667" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Sideropenic anemia and celiac disease: one study, two points of view.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8602182" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The prevalence of occult gastrointestinal bleeding in celiac sprue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23416278" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Association between celiac disease and iron deficiency in Caucasians, but not non-Caucasians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8855729" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Role of small bowel biopsy in the endoscopic evaluation of adults with iron deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12172415" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Extreme thrombocytosis as a sign of coeliac disease in the elderly: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12049314" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : On the pathogenesis and clinical course of mesenteric lymph node cavitation and hyposplenism in coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9855054" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Fatal pneumococcal septicaemia in a coeliac patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7769189" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Appropriate response to pneumococcal vaccine in celiac sprue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14716525" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Clinical and neurological abnormalities in adult celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12771245" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Celiac neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8975957" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality "trait" or a reactive illness?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9416814" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Neuromuscular disorder as a presenting feature of coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9666954" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Coeliac disease and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17030661" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Cognitive impairment and celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8598704" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Does cryptic gluten sensitivity play a part in neurological illness?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9843103" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11171906" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Headache and CNS white matter abnormalities associated with gluten sensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14984816" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Regional cerebral hypoperfusion in patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16476935" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4329557" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Neurological manifestations in adult steatorrhoea (probable Gluten enteropathy).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2832786" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Distal axonopathy associated with chronic gluten enteropathy: a treatable disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9466129" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22517096" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23126519" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Prevalence of migraine in patients with celiac disease and inflammatory bowel disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17030405" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Coeliac disease and risk of mood disorders--a general population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19183153" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17509100" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12640070" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Neuromuscular and sensory disturbances in patients with well treated coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8885812" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Prevalence and diagnosis of celiac disease in IgA-deficient children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9290622" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Celiac disease and selective immunoglobulin A deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11393550" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Celiac disease and its link to type 1 diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9472862" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9399754" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9260789" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10651264" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Autoantibodies to human tissue transgutaminase identify silent coeliac disease in Type I diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10975212" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10990078" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Development of celiac disease-associated antibodies in offspring of parents with type I diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11502314" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Mortality in patients with coeliac disease and their relatives: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19073967" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Shared and distinct genetic variants in type 1 diabetes and celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10441179" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10725775" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Autoantibodies predicting diabetes mellitus type I in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8737029" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10821223" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Children with coeliac disease and insulin dependent diabetes mellitus--growth, diabetes control and dietary intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10198339" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10585617" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Gluten-free diet prevents diabetes in NOD mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14519706" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8020817" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Coeliac disease and autoimmune thyroid disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11374722" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : HLA DQ2 and/or DQ8 is associated with celiac disease-specific autoantibodies to tissue transglutaminase in families with thyroid autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15208605" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Allergy prevalence in adult celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20601132" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21778897" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Increased incidence of eosinophilic esophagitis in children and adults with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17566042" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Eosinophilic oesophagitis and coeliac disease: is it just a casual association?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17635383" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Eosinophilic oesophagitis and coeliac disease: is there an association?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18070017" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Eosinophilic esophagitis in children with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19841598" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Celiac disease and eosinophilic esophagitis: a true association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3597021" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Increased association of ulcerative colitis and coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1150053" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Selective immunoglobulin a deficiency, ulcerative colitis, and gluten-sensitive enteropathy--a unique association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17918008" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19175939" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19455118" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2385735" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Epidemiological survey of coeliac disease and inflammatory bowel disease in first-degree relatives of coeliac patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23419379" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19631283" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : An association between microscopic colitis and celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9800742" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Coeliac disease hidden by cryptogenic hypertransaminasaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10051464" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Chronic unexplained hypertransaminasemia may be caused by occult celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21545472" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Meta-analysis: Coeliac disease and hypertransaminasaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15740533" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Systematic review: the liver in coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9518232" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9412913" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : High prevalence of celiac sprue among patients with primary biliary cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15017614" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Liver abnormalities in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17161656" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Celiac disease and risk of liver disease: a general population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17702659" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Risk of pancreatitis in 14,000 individuals with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22801059" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Patients with celiac disease have an increased risk for pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15825068" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25831067" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Increased rates of pregnancy complications in women with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10462981" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : [Age at menarche in girls with celiac disease].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7134839" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Coeliac disease, fertility, and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10972376" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21106194" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Latent celiac disease in reproductive performance of women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783766" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Female fertility, obstetric and gynaecological history in coeliac disease: a case control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10548618" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : The prevalence of coeliac disease in infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8949641" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Infertility and coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20337200" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Celiac disease and its effect on human reproduction: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23313966" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Levels of antibodies against tissue transglutaminase during pregnancy are associated with reduced fetal weight and birth weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10484005" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : Birth outcomes of women with celiac disease: a nationwide historical cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7988065" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : Infertility, obstetric and gynaecological problems in coeliac sprue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6682819" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Male gonadal function in coeliac disease: 2. Sex hormones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12045166" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : Celiac disease associated with autoimmune myocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10421311" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Prevalence of coeliac disease in idiopathic dilated cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19755695" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : Small-intestinal histopathology and mortality risk in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21262996" id="rid179" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>180 : Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17277354" id="rid180" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>181 : Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12860579" id="rid181" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>182 : Causes of death in patients with celiac disease in a population-based Swedish cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18162081" id="rid182" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>183 : The association between coeliac disease and cardiovascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12935825" id="rid183" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>184 : Risk of malignancy in patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid184" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>185 : History of celiac disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12404215" id="rid185" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>186 : Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21723236" id="rid186" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>187 : Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21289299" id="rid187" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>188 : Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32679218" id="rid188" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>189 : Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19362553" id="rid189" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>190 : Increased prevalence and mortality in undiagnosed celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2744350" id="rid190" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>191 : Mortality in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3992161" id="rid191" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>192 : Non-tropical sprue. Malignant diseases and mortality rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11903028" id="rid192" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>193 : Risk of non-Hodgkin lymphoma in celiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17206762" id="rid193" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>194 : Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15379837" id="rid194" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>195 : Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22288441" id="rid195" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>196 : The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
